Targeting aberrantly elevated sialyl lewis a as a potential therapy for impaired endometrial selection ability in unexplained recurrent miscarriage

HIGHLIGHTS

• who: Zhi Ma from the Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany have published the paper: Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage, in the Journal: (JOURNAL)
• what: This study shows a remarkably elevated glycosylation status in the decidua of uRM patients manifested by prominently upregulated sLeA, LeX, FUT3/4, and ST3GAL3/ 4, which might contribute to the hyper-receptive/less selective endometrium in RM.
• how: The staining results were analyzed using semiquantitative immunoreactive . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.